O‐18: mTORC1 is a novel HCV host factor

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|11-11

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTORC1 et sirolimus

By Tartarin Pauline   Froment Pascal  

Médecine/sciences, Vol. 29, Iss. 2, 2013-02 ,pp. : 200-205

Edp Sciences

Access to resources Recommend Favorite

mTORC1 and the regulation of skeletal muscle anabolism and mass

By Adegoke Olasunkanmi A.J.   Abdullahi Abdikarim   Tavajohi-Fini Pegah  

Applied Physiology, Nutrition, and Metabolism, Vol. 37, Iss. 3, 2012-06 ,pp. : 395-406

NRC Research Press

Access to resources Recommend Favorite

Coactivation d’AMPK et de mTORC1

By Tamburini Jérôme   Poulain Laury   Bouscary Didier   Sujobert Pierre  

Médecine/sciences, Vol. 31, Iss. 10, 2015-10 ,pp. : 836-839

Edp Sciences

Access to resources Recommend Favorite

Orexin A protects cells from apoptosis by regulating FoxO1 and mTORC1 through the OX1R/PI3K/AKT signaling pathway in hepatocytes

By        

International Journal of Molecular Medicine, Vol. 34, Iss. 1, 2014-01 ,pp. : 153-159

Spandidos Publications

Access to resources Recommend Favorite

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3481-3490

John Wiley & Sons Inc

Access to resources Recommend Favorite